You are here: Home » PTI Stories » National » News
Business Standard

Eris Lifesciences Q3 net up 10 pc at Rs 74.92 cr

Press Trust of India  |  New Delhi 

Drug firm today reported a 10.06 per cent rise in its consolidated net profit to Rs 74.92 crore for the quarter ended December 2017.

The company had posted a net profit of Rs 68.07 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a BSE filing.

Consolidated total income of the company also rose to Rs 214.75 crore for the quarter under consideration as against Rs 190 crore in the same period a year ago.

Shares of closed 0.35 per cent higher at Rs 765.05 per scrip on BSE today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, February 12 2018. 16:30 IST